Dacomitinib T2483
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Dacomitinib(PF299804; PF-00299804) is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with IC50 of 6, 45.7 and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively.
CAS nr:
1110813-31-4
Purity:
98%
Molecular Weight:
469,94
SMILES:
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC)/C=C/CN1CCCCC1
Formula:
C24H25ClFN5O2
Pathway:
JAK/STAT signaling,Tyrosine Kinase/Adaptors,Angiogenesis,Apoptosis
Target:
EGFR,EGFR,EGFR,Apoptosis
